20 employees
Nanosynex is a microfluidic diagnostic test for early detection of bacterial infections.
2017
$83K
from 1 investors over 1 rounds
Nanosynex raised $83K on June 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)